Cargando…
Biodegradable reduce expenditure bioreactor for augmented sonodynamic therapy via regulating tumor hypoxia and inducing pro-death autophagy
BACKGROUNDS: Sonodynamic therapy (SDT) as an emerging reactive oxygen species (ROS)-mediated antitumor strategy is challenged by the rapid depletion of oxygen, as well as the hypoxic tumor microenvironment. Instead of the presently available coping strategies that amplify the endogenous O(2) level,...
Autores principales: | Zou, Weijuan, Hao, Junnian, Wu, Jianrong, Cai, Xiaojun, Hu, Bing, Wang, Zhigang, Zheng, Yuanyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670251/ https://www.ncbi.nlm.nih.gov/pubmed/34903226 http://dx.doi.org/10.1186/s12951-021-01166-y |
Ejemplares similares
-
Correction: Biodegradable reduce expenditure bioreactor for augmented sonodynamic therapy via regulating tumor hypoxia and inducing pro‑death autophagy
por: Zou, Weijuan, et al.
Publicado: (2022) -
2D antimonene-integrated composite nanomedicine for augmented low-temperature photonic tumor hyperthermia by reversing cell thermoresistance
por: Wu, Jianrong, et al.
Publicado: (2021) -
Emerging nanosonosensitizers augment sonodynamic-mediated antimicrobial therapies
por: Xu, Qinglin, et al.
Publicado: (2023) -
Hypoxia modulation by dual-drug nanoparticles for enhanced synergistic sonodynamic and starvation therapy
por: Wang, Jingxue, et al.
Publicado: (2021) -
The crosstalk between sonodynamic therapy and autophagy in cancer
por: Zhang, Yujie, et al.
Publicado: (2022)